...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Nonprofit Think Tank
Reply New Message
Prev Message Back To Forum Threaded View Next Message

 it has not worked out well for hepa, dart etc so far just as it has not worked out for the retail shareholders.  If Hepa and Dart were as astute as you think, then why have they parked their funds in an investment that is going nowhere. 

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply